Drugs & Targets FDA approves neratinib for metastatic HER2-positive breast cancer February 28, 2020Vol.46 No.09
Drugs & Targets FDA accepts sNDA for Zejula in ovarian cancer indication February 28, 2020Vol.46 No.09
Drugs & Targets FDA grants RMAT designation to CD30 CAR-T Cell Therapy in hodgkin lymphoma indication February 28, 2020Vol.46 No.09
Drugs & Targets PMC report: FDA addressed rare diseases, expanded cancer treatment and targeted therapies in 2019 February 28, 2020Vol.46 No.09
Drugs & Targets Boehringer Ingelheim and Trutino Biosciences collaborate to grow cancer immunology portfolio with novel cytokine platform February 28, 2020Vol.46 No.09
Clinical Roundup Immunotherapy combination effective for patients with high-grade neuroendocrine cancer February 28, 2020Vol.46 No.09
Clinical Roundup Definitions of malnutrition apply differently depending on cancer type February 28, 2020Vol.46 No.09
In Brief Jennifer Cullen named associate director of Cancer Population Sciences at Case CCC February 28, 2020Vol.46 No.09
In Brief Aaron Gerds named medical director of Clinical Research Office at Case CCC February 28, 2020Vol.46 No.09
